SXTC

China SXT Pharmaceuticals, Inc. (ticker: SXTC) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of SXTC's SEC filings surfaces 4 active risk signals, including 3 late-filing signals, and 1 auditor-change signal. SXTC reported $829K in revenue and -$3.30M for the period ending 2024-09-30, with operating cash flow of -$2.35M. Cash and equivalents stood at $18.10M (up 49.9% year-over-year). Total assets of $21.66M exceed total liabilities of $6.22M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.